Invention Grant
- Patent Title: Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides
-
Application No.: US15787425Application Date: 2017-10-18
-
Publication No.: US10988544B2Publication Date: 2021-04-27
- Inventor: Gerard Zurawski , Jacques F. Banchereau , Anne-Laure Flamar , Yves Levy , Monica Montes
- Applicant: Baylor Research Institute
- Applicant Address: US TX Dallas
- Assignee: Baylor Research Institute
- Current Assignee: Baylor Research Institute
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/005 ; A61K39/385 ; G01N33/68 ; C07K16/00 ; A61K39/00
Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccines and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Public/Granted literature
- US20180094071A1 ANTIGEN PRESENTING CELL TARGETED VACCINES Public/Granted day:2018-04-05
Information query
